Muscle health problems are particularly prominent among Asian patients with type 2 diabetes, with 61% of the patients showing early signs of sarcopenia, 23% being diagnosed with sarcopenia, and 12.1% progressing to severe sarcopenia [9], placing a heavy financial burden on individuals, families, and public health systems
Expected Approval Timeline Retatrutide is still in clinical development
(ii) In human studies, this includes differences in race and patient age, as well as sex, diet, and drug use, which can cause changes in the composition of the gut bacterial microbiota and alter the relationship between plasma TMAO levels and atherosclerosis
Brain tissue is also rich in polyunsaturated lipids that can be damaged by oxidation
Insulin degludec: A significant advancement in ultralong-acting basal insulin